Literature DB >> 10355805

The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response.

N W Eames1, R Baker, N Hill, K Graham, T Taylor, A Cosgrove.   

Abstract

Thirty-nine ambulant children (22 with hemiplegia, 17 with diplegia) with spastic cerebral palsy receiving isolated gastrocnemius muscle injection with botulinum toxin A were studied prospectively. The children had a mean age of 6 years (range 3 to 13 years). Measurement of gastrocnemius muscle length was used to estimate the dynamic component of each child's spasticity and to quantify the response. There was a strong correlation between the dynamic component of spasticity before injection and the corresponding magnitude of the response after injection. Children undergoing repeated injections showed similar correlations. A strong correlation was found between the duration of response and the dynamic component. Children with hemiplegia showed twice the duration for a given dynamic component compared with those with diplegia when injected with the same total dose per unit body weight. Long-term lengthening did not occur for the cohort, although some patients showed a response at a 12-month follow-up. By delaying shortening, the injections may have a role in delaying the need for surgery. Injections were well tolerated with few side effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10355805     DOI: 10.1017/s0012162299000493

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  16 in total

Review 1.  Botulinum toxin for cerebral palsy; where are we now?

Authors:  R E Morton; J Hankinson; J Nicholson
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

2.  Anatomic localization of motor entry points and intramuscular nerve endings in the hamstring muscles.

Authors:  X C An; J H Lee; S Im; M S Lee; K Hwang; H W Kim; Seung-Ho Han
Journal:  Surg Radiol Anat       Date:  2010-01-10       Impact factor: 1.246

3.  The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb.

Authors:  Guy Molenaers; Anja Van Campenhout; Katrien Fagard; Jos De Cat; Kaat Desloovere
Journal:  J Child Orthop       Date:  2010-03-18       Impact factor: 1.548

Review 4.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

5.  Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.

Authors:  T Ubhi; B B Bhakta; H L Ives; V Allgar; S H Roussounis
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

Review 6.  Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.

Authors:  L Andrew Koman; Beth Paterson Smith; Rajesh Balkrishnan
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: a prospective study.

Authors:  Aviva Fattal-Valevski; Dafna Domenievitz; Nir Giladi; Shlomo Wientroub; Shlomo Hayek
Journal:  J Child Orthop       Date:  2008-01-23       Impact factor: 1.548

Review 8.  Botulinum toxin A (Dysport®): in dystonias and focal spasticity.

Authors:  Susan J Keam; Victoria J Muir; Emma D Deeks
Journal:  Drugs       Date:  2011-05-28       Impact factor: 11.431

9.  Quantitative effects on proximal joints of botulinum toxin treatment for gastrocnemius spasticity: a 4-year-old case study.

Authors:  Veronica Cimolin; Manuela Galli; Marcello Crivellini; Giorgio Albertini
Journal:  Case Rep Med       Date:  2009-08-26

10.  Gait analysis methods in rehabilitation.

Authors:  Richard Baker
Journal:  J Neuroeng Rehabil       Date:  2006-03-02       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.